EE113: Comparing Partitioned Survival and State Transition Modeling Approaches: A Case Study of Osimertinib Versus Pemetrexed-Platinum

EE277: Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand

EE311: Cost-Effectiveness Analysis of Ruxolitinib vs Best Available Therapy for the Treatment of Myelofibrosis in the United States

EE342: Compression Therapy with Early Endovenous Ablation in Venous Leg Ulceration in the U.S.: A Cost-Effectiveness Analysis

EE44: Cost-Effectiveness of Pembrolizumab in First-Line Treatment of PD-L1 Positive Persistent, Recurrent, or Metastatic Cervical Cancer

SA12: Can We Predicting Trial Failure Among Older Adult-Specific Clinical Trials Using Trial-Level Factors?